Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Pharmacotherapy
|
January 17, 2002
The emerging role of atypical pathogens in community-acquired pneumonia
Patrick P Gleason
Journal of Managed Care Pharmacy : JMCP
|
April 5, 2007
Assessing step-therapy programs:a step in the right direction
Patrick P Gleason
Journal of Managed Care & Specialty Pharmacy
|
January 28, 2025
Emerging trends in pharmaceutical payment models: Perspectives on the 2024 AMCP Foundation Survey
James T Kenney, Patrick P Gleason
Journal of Managed Care & Specialty Pharmacy
|
January 31, 2025
Emerging trends in pharmaceutical payment models: Perspectives on the 2024 AMCP Foundation Survey
James T Kenney, Patrick P Gleason
Journal of Managed Care & Specialty Pharmacy
|
November 29, 2019
Spinal Muscular Atrophy Therapies: ICER Grounds the Price to Value Conversation in Facts
Catherine I Starner, Patrick P Gleason
Journal of Managed Care Pharmacy : JMCP
|
July 4, 2008
Cholinesterase inhibitor utilization patterns: just because it can be counted does not mean it counts
Catherine I Starner, Patrick P Gleason
Journal of Managed Care & Specialty Pharmacy
|
October 25, 2022
Drug super spender tsunami: An integrated medical and pharmacy benefits assessment
Catherine I Starner, Kevin Bowen, Patrick P Gleason
Journal of Managed Care Pharmacy : JMCP
|
May 9, 2009
Critical review of prasugrel for formulary decision makers
Jeremy A Schafer, Nicole K Kjesbo, Patrick P Gleason
Journal of Managed Care Pharmacy : JMCP
|
November 12, 2010
Price increases and new drugs drive increased expenditures for multiple sclerosis
Jeremy A Schafer, Brent W Gunderson, Patrick P Gleason
Cardiovascular Therapeutics
|
January 16, 2010
Dronedarone: current evidence and future questions
Jeremy A Schafer, Nicole K Kjesbo, Patrick P Gleason
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Pharmacotherapy
|
January 17, 2002
The emerging role of atypical pathogens in community-acquired pneumonia
Patrick P Gleason
Journal of Managed Care Pharmacy : JMCP
|
April 5, 2007
Assessing step-therapy programs:a step in the right direction
Patrick P Gleason
Journal of Managed Care & Specialty Pharmacy
|
January 28, 2025
Emerging trends in pharmaceutical payment models: Perspectives on the 2024 AMCP Foundation Survey
James T Kenney, Patrick P Gleason
Journal of Managed Care & Specialty Pharmacy
|
January 31, 2025
Emerging trends in pharmaceutical payment models: Perspectives on the 2024 AMCP Foundation Survey
James T Kenney, Patrick P Gleason
Journal of Managed Care & Specialty Pharmacy
|
November 29, 2019
Spinal Muscular Atrophy Therapies: ICER Grounds the Price to Value Conversation in Facts
Catherine I Starner, Patrick P Gleason
Journal of Managed Care Pharmacy : JMCP
|
July 4, 2008
Cholinesterase inhibitor utilization patterns: just because it can be counted does not mean it counts
Catherine I Starner, Patrick P Gleason
Journal of Managed Care & Specialty Pharmacy
|
October 25, 2022
Drug super spender tsunami: An integrated medical and pharmacy benefits assessment
Catherine I Starner, Kevin Bowen, Patrick P Gleason
Journal of Managed Care Pharmacy : JMCP
|
May 9, 2009
Critical review of prasugrel for formulary decision makers
Jeremy A Schafer, Nicole K Kjesbo, Patrick P Gleason
Journal of Managed Care Pharmacy : JMCP
|
November 12, 2010
Price increases and new drugs drive increased expenditures for multiple sclerosis
Jeremy A Schafer, Brent W Gunderson, Patrick P Gleason
Cardiovascular Therapeutics
|
January 16, 2010
Dronedarone: current evidence and future questions
Jeremy A Schafer, Nicole K Kjesbo, Patrick P Gleason
Page
of 4